Sarcoma and Coronavirus: What Now?

Now that many states and localities are starting to lift shelter-in-place restrictions and move into phases of reopening, what do sarcoma patients need to know?

As a follow-up to our April session, the Sarcoma Foundation of America is reuniting the panel of sarcoma experts to share their thoughts on how COVID-19 may continue to impact care and what sarcoma patients need to know as we begin the phases of reopening. Our multidisciplinary panel will answer your questions and address concerns on issues of care, the impact on research and clinical trials, and next steps as we move forward.
Saturday, May 23, 2020
3:00 pm EDT

David Kirsch, MD, PhD
Barbara Levine University Professor
Professor and Vice Chair for Basic & Translational Research,
Department of Radiation Oncology
Professor, Department of Pharmacology & Cancer Biology
Duke University School of Medicine

Brian A. Van Tine, MD, PhD
Associate Professor of Medicine
Sarcoma Program Director
Barnes and Jewish Hospital
Washington University in St. Louis
Kurt R. Weiss, MD
Associate Professor University of Pittsburgh School of Medicine
Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology
Vice Chair of Translational Research
Director, Musculoskeletal Oncology Laboratory
University of Pittsburgh School of Medicine
Breelyn A. Wilky, MD
Associate Professor, Director of Sarcoma Translational Research
Department of Medicine, Division of Medical Oncology
Deputy Associate Director for Clinical Research,
University of Colorado Cancer Center
University of Colorado Anschutz Medical Campus

Discussion Format
SFA will collect questions in advance and through the chat during the discussion on Saturday, May 23 and the panelists will answer the questions live.
To join the discussion, REGISTER HERE and submit any questions you may have in advance. You can also submit questions through the chat feature during the event and anytime on social media using the hashtag #SarcomaScienceSaturday. 

This session is free and open to everyone, so please share with anyone you know who might be interested in joining the discussion.